Alzheimer proteins (tau and beta-amyloid proteins) control Alzheimer’s disease through 13 major biological pathways that are enriched by the targeted genes correlated to OEP-identified compounds. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.